Cathepsin G, A neutrophil-derived serine protease, Increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infection

Journal of Virology

Volumn 74, Issue 15, 2000, Pages 6849-6855

  Moriuchi, Hiroyuki ^a,b   Moriuchi, Masako ^a,b   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; CD4 ANTIGEN; PERTUSSIS TOXIN; SERINE PROTEINASE INHIBITOR;

ARTICLE; CHEMOTAXIS; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MACROPHAGE; PRIORITY JOURNAL;

CATHEPSINS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOTAXIS; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HIV-1; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; NEUTROPHILS; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 0033925796     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.15.6849-6855.2000     Document Type: Article

References (29)

1. Altieri, D. C. 1995. Proteases and protease receptors in modulation of leukocyte effector functions. J. Leukocyte Biol. 58:120-127.
2. Anderson, K. B., and H. Skov. 1989. Retrovirus-induced cell fusion is enhanced by protease treatment. J. Gen. Virol. 70:1921-1927.
3. Avril, L. E., M. Di Martino-Ferrer, G. Pignede, M. Seman, and F. Gauthier. 1994. Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin G. FEBS Lett. 345:81-86.
4. Blanchard, A., L. Montagnier, and M.-L. Gougeon. 1997. Influence of microbial infections on the progression of HIV disease. Trends Microbiol. 5:326-331.
5. Boyum, A. 1968. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Investig. 21(Suppl.):77-89.
6. Campbell, E. J., E. K. Silverman, and M. A. Campbell. 1989. Elastase and cathepsin G of human monocytes: quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J. Immunol. 143:2961-2968.
7. Chertov, O., H. Ueda, L. L. Xu, K. Tani, W. J. Murphy, J. M. Wang, O. M. Howard, T. J. Sayers, and J. J. Oppenheim. 1997. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 186:739-747.
8. Cohen, M. S. 1998. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 351:sIII5-sIII7.
9. Connor, R. L., K. E. Sheridan, C. Ceradini, S. Choe, and N. R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 185:621-628.
10. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
11. Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529-534.
12. Hase-Yamaguchi, T., and Y. Aoki, 1995. Stimulation of human lymphocytes by cathepsin G. Cell. Immunol. 160:24-35.
13. Ho, J. L., S. He, A. Hu, J. Geng, F. G. Basile, M. G. Almeida, A. Y. Saito, J. Laurence, and W. D. Johnson, Jr. 1995. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. J. Exp. Med. 181: 1493-1505.
14. McNeely, T. B., M. Dealy, D. J. Dripps, J. M. Orenstein, S. P. Eisenberg, and S. M. Wahl. 1995. Secretary leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Investig. 96:456-464.
15. McNeely, T. B., D. C. Shugars, M. Rosendahl, C. Tucker, S. P. Eisenberg, and S. M. Wahl. 1997. Inhibition of human immunodeficiency virus type 1 infectivity by secretary leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 90:1141-1149.
16. Moriuchi, H., M. Moriuchi, J. Arthos, J. Hoxie, and A. S. Fauci. 1997. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1. J. Virol. 71:9664-9671.
17. Moriuchi, H., M. Moriuchi, C. Combadiere, P. M. Murphy, and A. S. Fauci. 1996. CD8+ T-cell-derived factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages. Proc. Natl. Acad. Sci. USA 93:15341-15345.
18. Moriuchi, H., M. Moriuchi, and A. S. Fauci. 1997. Nuclear factor-κB potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158:3483-3491.
19. Moriuchi, H., M. Moriuchi, and A. S. Fauci. 1998. Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1. J. Exp. Med. 187:1689-1697.
20. Moriuchi, M., H. Moriuchi, S. E. Straus, and J. I. Cohen. 1994. Varicellazoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA. Virology 200:297-300.
21. Moriuchi, M., H. Moriuchi, W. Turner, and A. S. Fauci. 1998. Exposure to bacterial products renders macrophages highly susceptible to T-tropic human immunodeficiency virus type 1: implications for in vivo coinfections. J. Clin. Investig. 109:1540-1550.
22. Murphy, P. M. 1996. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Res. 7:47-64.
23. Poli, G., and A. S. Fauci. 1995. A role of cytokine in the pathogenesis of human immunodeficiency virus infection, p. 421-449. In B. Aggarwahl and R. Puri (ed.), Human cytokines: their role in disease and therapy. Blackwell Science, Cambridge, Mass.
24. Takahashi, H., T. Nukiwa, P. Basset, and R. G. Crystal. 1988. Myelomonocytic cell lineage expression of the neutrophil elastase gene. J. Biol. Chem. 263:543-547.
25. Tersmette, M., R. E. de Goede, B. J. Al, I. N. Winkel, R. A. Gruters, H. T. Cuypers, H. G. Huisman, and F. Miedema. 1988. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62:2026-2032.
26. Thompson, R. C., and K. Ohlsson. 1986. Isolation, properties, and complete amino acid sequence of human secretary leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. USA 83:6692-6696.
27. Travis, J., and G. S. Salvesen. 1983. Human plasma protease inhibitors. Annu. Rev. Biochem. 52:655-709.
28. Wahl, S. M., and J. M. Orenstein. 1997. Immune stimulation and HIV-1 viral replication. J. Leukocyte Biol. 62:67-71.
29. Zimmer, M., R. L. Medcalf, T. M. Fink, C. Mattmann, P. Lichter, and D. E. Jenne. 1992. Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc. Natl. Acad. Sci. USA 89:2228-2232.